Description: 2021 ImpACT Conference - Session 11E: Real World ESGs and the NAIC's ESG Project 10.28.21 Recording

Description: Electronic health records continue to evolve and gain traction in the life insurance industry. But what exactly are EHRs and what are the impacts for actuaries? How they are being used today and what are the benefits and challenges of implementing EHRs in life insurance underwriting?

Description: Telehealth continues to be a story of unrealized potential than realized success. Find out what's pushing telehealth forward as a means of remote healthcare and the challenges its facing. Discuss questions, including: - Telehealth's role in expanding access to mental healthcare is clear, but what about other conditions? - Was access expanded for all patients or do modern delivery methods leave some patients behind - How do telehealth costs compare to in-person costs? - What happens to the value proposition if unit cost savings is off the table?

Description: Join us to explore a variety of ways that COVID-19 has impacted retirement and how those impacts may extend into the future. Material from a series of research reports published through the SOA's Aging and Retirement Strategic Research Program will be presented as well as other relevant work. This content was originally presented at the 2021 SOA ImpACT Conference.

Description: With mortality rates significantly higher in 2020 and 2021 due to the COVID-19 pandemic, actuaries that rely on historical experience cannot properly craft assumptions about the future due to the recent excess deaths. This webcast focuses on the practicality of using pandemic mortality experience, as well as how to overcome the practical challenges of that data implementation. Explore an overview of different approaches used by institutions in the U.S., Canada and UK and an observation of industry survey responses. There will also be a comparison to recent SOA expert opinion surveys and short term impacts on the future of U.S. mortality.

Description: Recent and potential near future extreme experiences are leading us to a new normal rather than back to the prior environment. Learn more about several examples of past Regime Changes along with a detailed discussion of how recent disruptions lead toward a persistent change in the business, social and political environment. Come develop an understanding of these drivers of change as well as the likely impacts on the Financial Services industry.

Description: Defining fairness for life insurance processes is complex and challenging as well as subjective. This webcast will be a discussion of the challenges and opportunities presented as our profession rethinks fairness in the context of processes involved in developing and managing life insurance, especially risk classification.

Description: Learn about key topics affecting actuaries working in the dental insurance space! The session will include valuable information for health actuaries looking to better understand how dental fits into Medicaid, Medicare, commercial, and ACA markets.

Description: In this session, you will learn about key cost drivers in pharmacy trends, including but not limited to: New high-cost drugs, including gene therapies, that treat rare and/or expensive conditions such as spinal muscular atrophy (SMA), inherited retinal disease, hemophilia A and B, Duchenne muscular dystrophy (DMD), sickle cell anemia and cerebral adrenoleukodystrophy (CALD) Other cost drivers in the prescription drug category, including the emergence of GLP-1s, digital therapeutics, targeted immunomodulators, accelerated approval drugs and expanded indications The implications of the end of the COVID-19 Public Health Emergency (PHE) on the costs of COVID-19 vaccines, testing and treatment claims Downward influences on pharmacy costs, such as the availability of new generic drugs and biosimilars Emerging trends in pharmacy benefits manager (PBM) contracting, the initial portion of this discussion will be led by a pharmacist and former state pharmacy director.

Description: After three decades of relatively stable overall inflation trends, the United States has seen significant increases over the last twelve months. What could this mean for inflation in the medical sector? Explore past patterns between the two phenomena, and what drivers stakeholders can monitor to be best aware of what could be coming.